SEVOFLURANE Side Effects

6994053-4 | Hypoxia, Increased Bronchial Secretion, Nausea
on Sep 09, 2010 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with maintenance of anaesthesia, induction of anaesthesia and was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, increased bronchial secretion, nausea (What is nausea?). Sevoflurane dosage: . During the same period patient was treated with PROPOFOL MARUISHI (1%) (View Propofol Maruishi Review and Propofol Maruishi Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).

6988587-6 | Hypoxia, Increased Bronchial Secretion, Nausea
Patient was taking Sevoflurane (View Usage). Patient had the following side effects: hypoxia, increased bronchial secretion, nausea (What is nausea?) on Sep 09, 2010 from JAPAN Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with maintenance of anaesthesia, induction of anaesthesia and. Sevoflurane dosage: . During the same period patient was treated with PROPOFOL MARUISHI (1%) (View Propofol Maruishi Review and Propofol Maruishi Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).

6979583-3 | Hepatitis B
Adverse event was reported on Sep 13, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: 8.0%) was diagnosed with induction of anaesthesia, maintenance of anaesthesia and. Location: JAPAN , weighting 119.0 lb, After Sevoflurane was administered, patient had the following side effects: hepatitis b (What is hepatitis b?). During the same period patient was treated with FENTANYL CITRATE (100 Microgram) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ETIZOLAM (Form Strength: 0.5) (View Etizolam Review and Etizolam Label ), SERTRALINE HYDROCHLORIDE (Form Strength: 50) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), CHLORPROMAZINE HCL (Form Strength: 12.5) (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), PROMETHAZINE HCL (Form Strength: 25) (View Promethazine Hcl Review and Promethazine Hcl Label ), RABEPRAZOLE SODIUM (Form Strength: 10) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6965356-4 | Ventricular Tachycardia
on Aug 27, 2010 Female patient from CANADA , child 11 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, prophylaxis of nausea and vomiting and was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular tachycardia. Sevoflurane dosage: . During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).


6965354-0 | Hepatitis Fulminant
on Aug 26, 2010 Female patient from JAPAN , weighting 119.0 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with Sevoflurane (View Usage). Patient had the following side effects: hepatitis fulminant. Sevoflurane dosage: 8.0%. During the same period patient was treated with FENTANYL CITRATE (100 Microgram) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ETIZOLAM (Form Strength: 0.5) (View Etizolam Review and Etizolam Label ), SERTRALINE HYDROCHLORIDE (Form Strength: 50) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), CHLORPROMAZINE HCL (Form Strength: 12.5) (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), PROMETHAZINE HCL (Form Strength: 25) (View Promethazine Hcl Review and Promethazine Hcl Label ), RABEPRAZOLE SODIUM (Form Strength: 10) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6962150-5 | Grand Mal Convulsion
Patient was taking Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: grand mal convulsion on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 132.3 lb, . Sevoflurane dosage: . Patient was hospitalized.

6960957-1 | Hypoxia, Increased Bronchial Secretion, Nausea
Adverse event was reported on Aug 23, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) was diagnosed with maintenance of anaesthesia, induction of anaesthesia, antiemetic supportive care and. Location: JAPAN , weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: hypoxia, increased bronchial secretion, nausea (What is nausea?). During the same period patient was treated with PROPOFOL MARUISHI (1%) (View Propofol Maruishi Review and Propofol Maruishi Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DROPERIDOL (View Droperidol Review and Droperidol Label ).

6942458-X | Alanine Aminotransferase Increased, Hepatitis, International Normalised Ratio Increased
on Aug 17, 2010 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with prophylaxis, anaesthesia and was treated with Sevoflurane (View Usage). Patient had the following side effects: alanine aminotransferase increased, hepatitis (What is hepatitis?), international normalised ratio increased. Sevoflurane dosage: . During the same period patient was treated with FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6939255-8 | Hypoxia, Increased Bronchial Secretion, Nausea
on Aug 17, 2010 Female patient from JAPAN , 19 years of age, weighting 99.21 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, induction and maintenance of anaesthesia and was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: hypoxia, increased bronchial secretion, nausea (What is nausea?). Sevoflurane dosage: 1%. During the same period patient was treated with PROPOFOL MARUISHI (1%) (View Propofol Maruishi Review and Propofol Maruishi Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), DORMICUM (View Dormicum Review and Dormicum Label ), NITROUS OXIDE (150 L/min) (View Nitrous Oxide Review and Nitrous Oxide Label ), DROPERIDOL (View Droperidol Review and Droperidol Label ).

6928069-0 | Hepatic Failure, Liver Function Test Abnormal, Overdose
Patient was taking Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, liver function test abnormal, overdose on Aug 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 19 years of age, weighting 77.16 lb, was diagnosed with arthralgia and. Sevoflurane dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6925153-2 | Hepatic Failure, Liver Function Test Abnormal, Overdose
Adverse event was reported on Aug 06, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: Induction, Duration: 30-50 Minutes) was diagnosed with arthralgia and. Location: UNITED KINGDOM , weighting 77.16 lb, Patient had the following side effects: hepatic failure, liver function test abnormal, overdose. During the same period patient was treated with ACETAMINOPHEN (20 Doses Of 1 Gram Instead Of 525 Mg) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6922119-3 | Hypoxia, Increased Bronchial Secretion, Nausea
on Aug 03, 2010 Female patient from JAPAN , 19 years of age, weighting 99.21 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, induction and maintenance of anaesthesia and was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: hypoxia, increased bronchial secretion, nausea (What is nausea?). Sevoflurane dosage: 1%. During the same period patient was treated with PROPOFOL MARUISHI (1%) (View Propofol Maruishi Review and Propofol Maruishi Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), DORMICUM (View Dormicum Review and Dormicum Label ), NITROUS OXIDE (150 L/min) (View Nitrous Oxide Review and Nitrous Oxide Label ), DROPERIDOL (View Droperidol Review and Droperidol Label ).

6917708-6 | Hypoxia, Increased Bronchial Secretion, Nausea
on Aug 03, 2010 Female patient from JAPAN , 19 years of age, was diagnosed with maintenance of anaesthesia, induction of anaesthesia, induction and maintenance of anaesthesia, primary ciliary dyskinesia and was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, increased bronchial secretion, nausea (What is nausea?). Sevoflurane dosage: 0.5-1.5%. During the same period patient was treated with PROPOFOL MARUISHI (1%) (View Propofol Maruishi Review and Propofol Maruishi Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), DORMICUM (View Dormicum Review and Dormicum Label ), NITROUS OXIDE (4 L Per Minute) (View Nitrous Oxide Review and Nitrous Oxide Label ), DROPERIDOL (View Droperidol Review and Droperidol Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6914870-6 | Anaphylactic Reaction, Hypoxic-ischaemic Encephalopathy, Mental Impairment
Patient was taking Sevoflurane (View Usage). Patient had the following side effects: anaphylactic reaction, hypoxic-ischaemic encephalopathy, mental impairment on Jul 30, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, . Sevoflurane dosage: . During the same period patient was treated with THIAMYLAL SODIUM (View Thiamylal Sodium Review and Thiamylal Sodium Label ), CEFMETAZOLE SODIUM (View Cefmetazole Sodium Review and Cefmetazole Sodium Label ). Patient was hospitalized and became disabled.

6909669-0 | Hepatitis Fulminant
Adverse event was reported on Jul 28, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) was diagnosed with sedation and. Location: JAPAN , 30 years of age, After Sevoflurane was administered, patient had the following side effects: hepatitis fulminant.

6887880-5 | Anaphylactic Reaction, Hypoxic-ischaemic Encephalopathy, Mental Impairment
on Jul 22, 2010 Female patient from JAPAN , 74 years of age, was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, hypoxic-ischaemic encephalopathy, mental impairment. Sevoflurane dosage: . During the same period patient was treated with THIAMYLAL SODIUM (View Thiamylal Sodium Review and Thiamylal Sodium Label ), CEFMETAZOLE SODIUM (View Cefmetazole Sodium Review and Cefmetazole Sodium Label ). Patient was hospitalized and became disabled.

6878511-9 | Anaphylactic Reaction, Hypoxic-ischaemic Encephalopathy, Mental Impairment
on Jul 16, 2010 Female patient from JAPAN , 72 years of age, was treated with Sevoflurane (View Usage). Patient had the following side effects: anaphylactic reaction, hypoxic-ischaemic encephalopathy, mental impairment. Sevoflurane dosage: .

6877382-4 | Activated Partial Thromboplastin Time Abnormal, Anaesthetic Complication, Blood Disorder, Cyanosis, Pulmonary Haemorrhage, Ventricular Dysfunction
Patient was taking Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: activated partial thromboplastin time abnormal, anaesthetic complication, blood disorder, cyanosis, pulmonary haemorrhage, ventricular dysfunction on Jul 20, 2010 from BRAZIL Additional patient health information: Male patient , weighting 10.80 lb, was diagnosed with induction and maintenance of anaesthesia and. Sevoflurane dosage: . Patient was hospitalized.

6862318-2 | Poor Quality Sleep
Adverse event was reported on Jul 18, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) . Location: PHILIPPINES , 67 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: poor quality sleep.

6844737-3 | Cardiac Arrest
on Jun 22, 2010 Female patient from UNITED STATES , child 7 years of age, was treated with Sevoflurane (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Sevoflurane dosage: .

6844716-6 | Alanine Aminotransferase Increased, Hepatitis, International Normalised Ratio Increased
on Jul 07, 2010 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with anaphylactic reaction, prophylaxis, anaesthesia and was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: alanine aminotransferase increased, hepatitis (What is hepatitis?), international normalised ratio increased. Sevoflurane dosage: . During the same period patient was treated with FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6839916-5 | Alanine Aminotransferase Increased, Hepatitis, International Normalised Ratio Increased
Patient was taking Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, hepatitis (What is hepatitis?), international normalised ratio increased on Jul 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 75 years of age, was diagnosed with anaphylactic reaction, prophylaxis, anaesthesia and. Sevoflurane dosage: . During the same period patient was treated with FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), MORPHINE (View Morphine Review and Morphine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6832724-0 | Poor Quality Sleep
Adverse event was reported on Jul 06, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) . Location: PHILIPPINES , 67 years of age, weighting 110.2 lb, Patient had the following side effects: poor quality sleep.

6824159-1 | Ischaemia
on Jun 28, 2010 Male patient from UNITED KINGDOM , child 4 years of age, weighting 33.07 lb, was diagnosed with maintenance of anaesthesia, epidural anaesthesia, induction of anaesthesia, endotracheal intubation and was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: ischaemia. Sevoflurane dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LEVOBUPIVACAINE (15ml Of 0.25%) (View Levobupivacaine Review and Levobupivacaine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), PROPOFOL (View Propofol Review and Propofol Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ).

6817547-0 | Cardiac Arrest, Torsade De Pointes, Ventricular Extrasystoles
on Jun 22, 2010 Female patient from AUSTRALIA , 79 years of age, was diagnosed with renal cell carcinoma and was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), torsade de pointes, ventricular extrasystoles. Sevoflurane dosage: 1 Mac, Once. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

6794936-4 | Activated Partial Thromboplastin Time Abnormal, Anaesthetic Complication, Blood Disorder, Cyanosis, Pulmonary Haemorrhage, Ventricular Dysfunction
Patient was taking Sevoflurane (View Usage). Patient had the following side effects: activated partial thromboplastin time abnormal, anaesthetic complication, blood disorder, cyanosis, pulmonary haemorrhage, ventricular dysfunction on Jun 17, 2010 from BRAZIL Additional patient health information: Male patient , weighting 10.80 lb, was diagnosed with induction and maintenance of anaesthesia and. Sevoflurane dosage: . Patient was hospitalized.

6794800-0 | Acute Pulmonary Oedema, Delayed Recovery From Anaesthesia, Hypokinesia, Hypotonia, Nuclear Magnetic Resonance Imaging Brain Abnormal
Adverse event was reported on Jun 21, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) was diagnosed with induction of anaesthesia, tonsillectomy and. Location: VENEZUELA , child 6 years of age, After Sevoflurane was administered, patient had the following side effects: acute pulmonary oedema, delayed recovery from anaesthesia, hypokinesia, hypotonia, nuclear magnetic resonance imaging brain abnormal. During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ). Patient was hospitalized and became disabled.

6780316-4 | Torsade De Pointes
on Jun 10, 2010 Female patient from AUSTRALIA , 79 years of age, was diagnosed with anaesthesia, induction of anaesthesia and was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: torsade de pointes. Sevoflurane dosage: . During the same period patient was treated with GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN (View Metformin Review and Metformin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), MIDAZOLAM HCL (Before Inductation) (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ).

6780269-9 | Activated Partial Thromboplastin Time Abnormal, Anaesthetic Complication, Blood Disorder, Cyanosis, Pulmonary Haemorrhage, Ventricular Dysfunction
on Jun 08, 2010 Male patient from BRAZIL , weighting 10.80 lb, was diagnosed with induction and maintenance of anaesthesia and was treated with Sevoflurane (View Usage). Patient had the following side effects: activated partial thromboplastin time abnormal, anaesthetic complication, blood disorder, cyanosis, pulmonary haemorrhage, ventricular dysfunction. Sevoflurane dosage: . Patient was hospitalized.

6764969-2 | Anaesthetic Complication, Blood Disorder, Pulmonary Haemorrhage
Patient was taking Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: anaesthetic complication, blood disorder, pulmonary haemorrhage on Jun 01, 2010 from BRAZIL Additional patient health information: Male patient , weighting 10.80 lb, was diagnosed with induction and maintenance of anaesthesia and. Sevoflurane dosage: . Patient was hospitalized.

6764892-3 | Atrioventricular Block Complete, Cardiovascular Insufficiency
Adverse event was reported on Jun 01, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: 2%) was diagnosed with induction and maintenance of anaesthesia and. Location: JAPAN , weighting 27.78 lb, Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, cardiovascular insufficiency. During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), DIURETIC AGENTS (View Diuretic Agents Review and Diuretic Agents Label ), INOTROPIC AGENTS (View Inotropic Agents Review and Inotropic Agents Label ), VASODEPRESSORS (View Vasodepressors Review and Vasodepressors Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), ADRENALINE (View Adrenaline Review and Adrenaline Label ).

6745598-3 | Electrocardiogram Qt Prolonged, Torsade De Pointes, Ventricular Extrasystoles
on May 19, 2010 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with anaesthesia, endotracheal intubation, hypotonia, induction of anaesthesia, blood pressure abnormal, blood pressure management and was treated with Sevoflurane (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, torsade de pointes, ventricular extrasystoles. Sevoflurane dosage: 1% X 6 L. During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), PROPOFOL (View Propofol Review and Propofol Label ), ETILEFRINE HYDROCHLORIDE (View Etilefrine Hydrochloride Review and Etilefrine Hydrochloride Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ).

6745025-6 | Pulmonary Oedema
on May 17, 2010 Female patient from JAPAN , weighting 88.18 lb, was diagnosed with hypertension, hypokalaemia, hyperglycaemia, diabetes mellitus, anaesthesia, hypotonia and was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: pulmonary oedema. Sevoflurane dosage: 4.0-1.0 Percent. During the same period patient was treated with ALDOMET (View Aldomet Review and Aldomet Label ), SLOW K (View Slow-k Review and Slow-k Label ), INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), ULTIVA (View Ultiva Review and Ultiva Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), MUSCURATE (View Muscurate Review and Muscurate Label ), ROPIVACAINE HYDROCHLORIDE (View Ropivacaine Hydrochloride Review and Ropivacaine Hydrochloride Label ). Patient was hospitalized.

6744984-5 | Acute Respiratory Distress Syndrome, Adrenal Insufficiency, Premature Baby
Patient was taking Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, adrenal insufficiency, premature baby on May 17, 2010 from JAPAN Additional patient health information: Male patient , weighting 1.05 lb, . Sevoflurane dosage: .

6744933-X | Bradycardia, Cardiac Arrest
Adverse event was reported on May 24, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) was diagnosed with anaesthesia, antibiotic prophylaxis and. Location: AUSTRALIA , child 9 years of age, Patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?). During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), CEFOXITIN (View Cefoxitin Review and Cefoxitin Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

6744745-7 | Muscle Rigidity, Respiration Abnormal, Respiratory Failure, Tachycardia
on May 24, 2010 Female patient from AUSTRALIA , 40 years of age, weighting 110.2 lb, was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: muscle rigidity, respiration abnormal, respiratory failure, tachycardia. Sevoflurane dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), GLYCOPYRROLATE INJECTION, USP (View Glycopyrrolate Injection, Usp Review and Glycopyrrolate Injection, Usp Label ), KETAMINE HYDROCHLORIDE (View Ketamine Hydrochloride Review and Ketamine Hydrochloride Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), CISATRACURIUM BESYLATE (View Cisatracurium Besylate Review and Cisatracurium Besylate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).

6736857-9 | Atrioventricular Block Complete, Cardiovascular Insufficiency, Dental Caries, Tooth Extraction
on May 12, 2010 Female patient from JAPAN , child 10 years of age, weighting 27.78 lb, was diagnosed with induction and maintenance of anaesthesia and was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, cardiovascular insufficiency, dental caries, tooth extraction. Sevoflurane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), DIURETIC AGENTS (View Diuretic Agents Review and Diuretic Agents Label ), INOTROPIC AGENTS (View Inotropic Agents Review and Inotropic Agents Label ), VASODEPRESSORS (View Vasodepressors Review and Vasodepressors Label ).

6726633-5 | Rhabdomyolysis
Patient was taking Sevoflurane (View Usage). Patient had the following side effects: rhabdomyolysis on May 06, 2010 from JAPAN Additional patient health information: Male patient , child 4 years of age, was diagnosed with induction and maintenance of anaesthesia and. Sevoflurane dosage: . During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ). Patient was hospitalized.

6716560-1 | Atrioventricular Block Complete, Cardiovascular Insufficiency
Adverse event was reported on May 06, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) was diagnosed with induction and maintenance of anaesthesia and. Location: JAPAN , child 10 years of age, weighting 27.78 lb, After Sevoflurane was administered, patient had the following side effects: atrioventricular block complete, cardiovascular insufficiency. During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), DIURETIC AGENTS (View Diuretic Agents Review and Diuretic Agents Label ), INOTROPIC AGENTS (View Inotropic Agents Review and Inotropic Agents Label ), VASODEPRESSORS (View Vasodepressors Review and Vasodepressors Label ).

6714365-9 | Atrioventricular Block Complete, Cardiovascular Insufficiency
on Apr 21, 2010 Female patient from JAPAN , child 10 years of age, weighting 27.78 lb, was diagnosed with induction and maintenance of anaesthesia and was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, cardiovascular insufficiency. Sevoflurane dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), DIURETIC AGENTS (View Diuretic Agents Review and Diuretic Agents Label ), INOTROPIC AGENTS (View Inotropic Agents Review and Inotropic Agents Label ), VASODEPRESSORS (View Vasodepressors Review and Vasodepressors Label ).

6704739-4 | Electrocardiogram Qt Prolonged, Ventricular Extrasystoles, Ventricular Tachycardia
on Apr 21, 2010 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with endotracheal intubation, anaesthesia, labile hypertension and was treated with Sevoflurane (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, ventricular extrasystoles, ventricular tachycardia. Sevoflurane dosage: 1%x14hrsx6l/min. During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), REMIFENTANIL HYDROCHLORIDE (View Remifentanil Hydrochloride Review and Remifentanil Hydrochloride Label ), DOPAMINE HYDROCHLORIDE (12 Microliter/hr) (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ).

6704734-5 | Electrocardiogram Qt Prolonged, Torsade De Pointes
Patient was taking Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: electrocardiogram qt prolonged, torsade de pointes on Apr 21, 2010 from JAPAN Additional patient health information: Female patient , weighting 94.80 lb, was diagnosed with anaesthesia, endotracheal intubation, induction of anaesthesia, blood pressure abnormal, blood pressure management and. Sevoflurane dosage: 1% X 6 L. During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), PROPOFOL (View Propofol Review and Propofol Label ), ETILEFRINE HYDROCHLORIDE (View Etilefrine Hydrochloride Review and Etilefrine Hydrochloride Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ).

6703999-3 | Grand Mal Convulsion
Adverse event was reported on Apr 23, 2010 by a Female patient taking Sevoflurane (View Usage) (Dosage: ) . Location: TUNISIA , child 8 years of age, Patient experienced the following unwanted or unexpected effects: grand mal convulsion.

6700968-4 | Anaphylactic Reaction
on Apr 21, 2010 Male patient from UNITED STATES , child 5 years of age, was diagnosed with anaesthesia and was treated with Sevoflurane (View Usage). Patient had the following side effects: anaphylactic reaction. Sevoflurane dosage: Not Reported. During the same period patient was treated with IOPAMIDOL (6ml Test Dose, Four Minutes Later 34ml) (View Iopamidol Review and Iopamidol Label ), SUCCINYLCHOLINE CHLORIDE (Not Reported) (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ).

6692281-9 | Bradycardia, Cardiac Arrest, Electrocardiogram Qt Prolonged, Nodal Arrhythmia
on Apr 12, 2010 Male patient from UNITED KINGDOM , child 4 years of age, weighting 37.48 lb, was diagnosed with tooth extraction and was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, nodal arrhythmia. Sevoflurane dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6691591-9 | Bradycardia, Cardiac Arrest, Electrocardiogram Qt Prolonged, Nodal Arrhythmia
Patient was taking Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, nodal arrhythmia on Apr 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 4 years of age, weighting 37.48 lb, was diagnosed with tooth extraction and. Sevoflurane dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6690227-0 | Anaphylactic Reaction
Adverse event was reported on Apr 16, 2010 by a Male patient taking Sevoflurane (View Usage) (Dosage: Not Reported) was diagnosed with anaesthesia and. Location: UNITED STATES , child 5 years of age, Patient had the following side effects: anaphylactic reaction. During the same period patient was treated with IOPAMIDOL (6ml Test Dose, Four Minutes Later 34ml) (View Iopamidol Review and Iopamidol Label ), SUCCINYLCHOLINE CHLORIDE (Not Reported) (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ).

6689765-6 | Acute Pulmonary Oedema, Delayed Recovery From Anaesthesia, Hypokinesia, Hypotonia, Nuclear Magnetic Resonance Imaging Brain Abnormal
on Apr 13, 2010 Female patient from VENEZUELA , child 6 years of age, was diagnosed with induction of anaesthesia, tonsillectomy and was treated with Sevoflurane (View Usage). After Sevoflurane was administered, patient had the following side effects: acute pulmonary oedema, delayed recovery from anaesthesia, hypokinesia, hypotonia, nuclear magnetic resonance imaging brain abnormal. Sevoflurane dosage: . During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ). Patient was hospitalized and became disabled.

6689099-X | Hepatic Necrosis, Hepatotoxicity
on Apr 15, 2010 Male patient from UNITED STATES , 37 years of age, was treated with Sevoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic necrosis, hepatotoxicity. Sevoflurane dosage: . During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), ACETAMINOPHEN (2-3 Times/day) (View Acetaminophen Review and Acetaminophen Label ), CODEINE SULFATE (2-3 Times/day) (View Codeine Sulfate Review and Codeine Sulfate Label ). Patient was hospitalized.

6687638-6 | Aspiration, Cardiac Failure, Circulatory Collapse, Coronary Artery Embolism, Dilatation Ventricular, Ejection Fraction Decreased, Ischaemic Cardiomyopathy, Left Ventricular Dysfunction, Myocardial Infarction
Patient was taking Sevoflurane (View Usage). Patient had the following side effects: aspiration, cardiac failure, circulatory collapse, coronary artery embolism, dilatation ventricular, ejection fraction decreased, ischaemic cardiomyopathy, left ventricular dysfunction, myocardial infarction on Apr 09, 2010 from FRANCE Additional patient health information: Female patient , 20 years of age, was diagnosed with anaesthesia and. Sevoflurane dosage: Once. During the same period patient was treated with CEFALOTINE (View Cefalotine Review and Cefalotine Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DOPRAM (View Dopram Review and Dopram Label ), ADRENALIN (View Adrenalin Review and Adrenalin Label ), TROPONINE (Dose Decreased) (View Troponine Review and Troponine Label ). Patient was hospitalized.